REFERENCES

REFERENCES

1 Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV . Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 381–90. 2 Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9 (5): 641–50. 3 Horwitz EM, Le Blanc K, Dominici M et al. ; International Society for Cellular Therapy . Clarification of the nomenclature for MSC: CRISPR-Cas9 , clustered regularly interspaced short palindromic repeats and associated protein 9. Resulted in the Nobel Prize in Chemistry being awarded to Emmanuelle Charpentier and Jennifer A. Doudna in 2020. Cytotherapy 2005; 7 (5): 393–5. 4 Dominici M, Le Blanc K, Mueller I et al . Minimal criteria for defin - ing multipotent mesenchymal stromal cells. The International Soci - ety for Cellular Therapy position statement. Cytotherapy 2006; 8 (4): - 315–17. 5 Caplan AI. Mesenchymal stem cells: time to change the name! Stem - Cells Transl Med 2017; 6 : 1445–51. 6 Sipp D, Robey PG, Turner L. Clear up this stem-cell mess. Nature 2018; 561 : 455–7. 7 Viswanathan S, Shi Y , Galipeau J et al . Mesenchymal stem versus ® stromal cells: International Society for Cell & Gene Therapy (ISCT ) Mesenchymal Stromal Cell committee position statement on nomen - clature. Cytotherapy 2019; 21 (10): 1019–24. 8 Murray IR, Chahla J, Safran M et al . International expert consen - sus on a cell therapy communication tool: DOSES. J Bone Joint Surg - 2019; 101 (10): 904–11. 9 Thomson JA, Itskovitz-Eldor J, Shapiro SS et al . Embryonic stem cell lines derived from human blastocysts. Science 1998; 282 (5391): - 1145-7. Erratum in: Science 1998; 282 (5395): 1827. - 10 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663-76. 11 Gurdon JB. The developmental capacity of nuclei taken from intesti - nal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962; 10 : 622-40. REFERENCES

1 Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV . Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 381–90. 2 Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9 (5): 641–50. 3 Horwitz EM, Le Blanc K, Dominici M et al. ; International Society for Cellular Therapy . Clarification of the nomenclature for MSC: CRISPR-Cas9 , clustered regularly interspaced short palindromic repeats and associated protein 9. Resulted in the Nobel Prize in Chemistry being awarded to Emmanuelle Charpentier and Jennifer A. Doudna in 2020. Cytotherapy 2005; 7 (5): 393–5. 4 Dominici M, Le Blanc K, Mueller I et al . Minimal criteria for defin - ing multipotent mesenchymal stromal cells. The International Soci - ety for Cellular Therapy position statement. Cytotherapy 2006; 8 (4): - 315–17. 5 Caplan AI. Mesenchymal stem cells: time to change the name! Stem - Cells Transl Med 2017; 6 : 1445–51. 6 Sipp D, Robey PG, Turner L. Clear up this stem-cell mess. Nature 2018; 561 : 455–7. 7 Viswanathan S, Shi Y , Galipeau J et al . Mesenchymal stem versus ® stromal cells: International Society for Cell & Gene Therapy (ISCT ) Mesenchymal Stromal Cell committee position statement on nomen - clature. Cytotherapy 2019; 21 (10): 1019–24. 8 Murray IR, Chahla J, Safran M et al . International expert consen - sus on a cell therapy communication tool: DOSES. J Bone Joint Surg - 2019; 101 (10): 904–11. 9 Thomson JA, Itskovitz-Eldor J, Shapiro SS et al . Embryonic stem cell lines derived from human blastocysts. Science 1998; 282 (5391): - 1145-7. Erratum in: Science 1998; 282 (5395): 1827. - 10 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663-76. 11 Gurdon JB. The developmental capacity of nuclei taken from intesti - nal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962; 10 : 622-40. REFERENCES

1 Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV . Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 381–90. 2 Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9 (5): 641–50. 3 Horwitz EM, Le Blanc K, Dominici M et al. ; International Society for Cellular Therapy . Clarification of the nomenclature for MSC: CRISPR-Cas9 , clustered regularly interspaced short palindromic repeats and associated protein 9. Resulted in the Nobel Prize in Chemistry being awarded to Emmanuelle Charpentier and Jennifer A. Doudna in 2020. Cytotherapy 2005; 7 (5): 393–5. 4 Dominici M, Le Blanc K, Mueller I et al . Minimal criteria for defin - ing multipotent mesenchymal stromal cells. The International Soci - ety for Cellular Therapy position statement. Cytotherapy 2006; 8 (4): - 315–17. 5 Caplan AI. Mesenchymal stem cells: time to change the name! Stem - Cells Transl Med 2017; 6 : 1445–51. 6 Sipp D, Robey PG, Turner L. Clear up this stem-cell mess. Nature 2018; 561 : 455–7. 7 Viswanathan S, Shi Y , Galipeau J et al . Mesenchymal stem versus ® stromal cells: International Society for Cell & Gene Therapy (ISCT ) Mesenchymal Stromal Cell committee position statement on nomen - clature. Cytotherapy 2019; 21 (10): 1019–24. 8 Murray IR, Chahla J, Safran M et al . International expert consen - sus on a cell therapy communication tool: DOSES. J Bone Joint Surg - 2019; 101 (10): 904–11. 9 Thomson JA, Itskovitz-Eldor J, Shapiro SS et al . Embryonic stem cell lines derived from human blastocysts. Science 1998; 282 (5391): - 1145-7. Erratum in: Science 1998; 282 (5395): 1827. - 10 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663-76. 11 Gurdon JB. The developmental capacity of nuclei taken from intesti - nal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962; 10 : 622-40.